Therapies for Psoriasis: Clinical and Economic Comparisons.
J Drugs Dermatol
; 19(11): 1101-1108, 2020 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: covidwho-941793
ABSTRACT
BACKGROUND:
Clinical and economic comparisons of therapies for plaque psoriasis are regularly updated following each new devel- opment in the field. With the recent availability of a novel accessory (Multi Micro DoseTM [MMD®] tip) for the 308nm excimer laser (XTRAC®, Strata Skin Sciences, Horsham, PA), which can determine and deliver an optimal therapeutic dose (OTDTM) of ultraviolet-B light in an improved protocol, the need for comparative health-economic assessment recurs. To this end, a comprehensive evaluation of treatment-related costs was undertaken from the payer perspective. Results show that outcomes are influenced by many factors; most importantly, the severity and extent of disease, treatment selection, and patient preference, as well as compliance, adherence, and persistence with care. Among study comparators, the 308nm excimer laser – XTRAC – with its latest MMD enhancement, is safe and delivers incremental clinical benefits with the potential for significant cost savings. These benefits are particularly relevant today in the context of SARS-CoV-2 virus and the COVid-19 pandemic. J Drugs Dermatol. 2020;19(11)1101-1108. doi10.36849/JDD.2020.5510.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Neumonía Viral
/
Psoriasis
/
Costos de la Atención en Salud
/
Infecciones por Coronavirus
/
Pandemias
Tipo de estudio:
Estudio experimental
/
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
J Drugs Dermatol
Asunto de la revista:
Dermatologia
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS